Expression of BAFF and BAFF‐R in the synovial tissue of patients with rheumatoid arthritis

References

• Harris E. D Jr. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 1990; 322: 1277–89
   PubMed Web of Science ®Google Scholar
• Magalhaes R., Stiehl P., Morawietz L., Berek C., Krenn V. Morphological and molecular pathology of the B cell response in synovitis of rheumatoid arthritis. Virchows Arch 2002; 441: 415–27
   PubMed Web of Science ®Google Scholar
• Feldmann M., Brennan F. M., Maini R. N. Rheumatoid arthritis. Cell 1996; 85: 307–10
   PubMed Web of Science ®Google Scholar
• Weyand C. M., Goronzy J. J. Ectopic germinal center formation in rheumatoid synovitis. Ann N Y Acad Sci 2003; 987: 140–9
   PubMed Web of Science ®Google Scholar
• Seyler T. M., Park Y. W., Takemura S., Bram R. J., Kurtin P. J., Goronzy J. J., et al. BLyS and APRIL in rheumatoid arthritis. J Clin Invest 2005; 115: 3083–92
   PubMed Web of Science ®Google Scholar
• Edwards J. C., Szczepanski L., Szechinski J., Filipowicz‐Sosnowska A., Emery P., Close D. R., et al. Efficacy of B‐cell‐targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004; 350: 2572–81
   PubMed Web of Science ®Google Scholar
• Schneider P., MacKay F., Steiner V., Hofmann K., Bodmer J. L., Holler N., et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 1999; 189: 1747–56
   PubMed Web of Science ®Google Scholar
• Moore P. A., Belvedere O., Orr A., Pieri K., LaFleur D. W., Feng P., et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 1999; 285: 260–3
   PubMed Web of Science ®Google Scholar
• Mackay F., Schneider P., Rennert P., Browning J. BAFF and APRIL: a tutorial on B cell survival. Annu Rev Immunol 2003; 21: 231–64
   PubMed Web of Science ®Google Scholar
• Groom J., Kalled S. L., Cutler A. H., Olson C., Woodcock S. A., Schneider P., et al. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J Clin Invest 2002; 109: 59–68
   PubMed Web of Science ®Google Scholar
• Cheema G. S., Roschke V., Hilbert D. M., Stohl W. Elevated serum B lymphocyte stimulator levels in patients with systemic immune‐based rheumatic diseases. Arthritis Rheum 2001; 44: 1313–19
   PubMed Web of Science ®Google Scholar
• Zhang J., Roschke V., Baker K. P., Wang Z., Alarcon G. S., Fessler B. J., et al. Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol 2001; 166: 6–10
   PubMed Web of Science ®Google Scholar
• Tan S. M., Xu D., Roschke V., Perry J. W., Arkfeld D. G., Ehresmann G. R., et al. Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis Rheum 2003; 48: 982–92
   PubMed Web of Science ®Google Scholar
• Batten M., Groom J., Cachero T. G., Qian F., Schneider P., Tschopp J., et al. BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med 2000; 192: 1453–66
   PubMed Web of Science ®Google Scholar
• Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24
   PubMed Web of Science ®Google Scholar
• Grabner R., Till U., Heller R. Flow cytometric determination of E‐selectin, vascular cell adhesion molecule‐1, and intercellular cell adhesion molecule‐1 in formaldehyde‐fixed endothelial cell monolayers. Cytometry 2000; 40: 238–44
   PubMedGoogle Scholar
• Schmid I., Uittenbogaart C. H., Keld B., Giorgi J. V. A rapid method for measuring apoptosis and dual‐color immunofluorescence by single laser flow cytometry. J Immunol Methods 1994; 170: 145–57
   PubMed Web of Science ®Google Scholar
• Nicoletti I., Migliorati G., Pagliacci M. C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991; 139: 271–9
   PubMed Web of Science ®Google Scholar
• Koizumi F., Matsuno H., Wakaki K., Ishii Y., Kurashige Y., Nakamura H. Synovitis in rheumatoid arthritis: scoring of characteristic histopathological features. Pathol Int 1999; 49: 298–304
   PubMed Web of Science ®Google Scholar
• Ng L. G., Sutherland A. P., Newton R., Qian F., Cachero T. G., Scott M. L., et al. B cell‐activating factor belonging to the TNF family (BAFF)‐R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J Immunol 2004; 173: 807–17
   PubMed Web of Science ®Google Scholar
• Shiokawa S., Matsumato N., Nishimura J. Clonal analysis of B cells in the synovial membrane of patients with rheumatoid arthritis. Scand J Rheumatol 2003; 32: 12–18
   PubMed Web of Science ®Google Scholar
• Kim H. J., Krenn V., Steinhauser G., Berek C. Plasma cell development in synovial germinal centers in patients with rheumatoid and reactive arthritis. J Immunol 1999; 162: 3053–62
   PubMed Web of Science ®Google Scholar
• Itoh K., Meffre E., Albesiano E., Farber A., Dines D., Stein P., et al. Immunoglobulin heavy chain variable region gene replacement as a mechanism for receptor revision in rheumatoid arthritis synovial tissue B lymphocytes. J Exp Med 2000; 192: 1151–64
   PubMed Web of Science ®Google Scholar
• Miura Y., Chu C. C., Dines D. M., Asnis S. E., Furie R. A., Chiorazzi N. Diversification of the Ig variable region gene repertoire of synovial B lymphocytes by nucleotide insertion and deletion. Mol Med 2003; 9: 166–74
   PubMed Web of Science ®Google Scholar
• Ohata J., Zvaifler N. J., Nishio M., Boyle D. L., Kalled S. L., Carson D. A., et al. Fibroblast‐like synoviocytes of mesenchymal origin express functional B cell‐activating factor of the TNF family in response to proinflammatory cytokines. J Immunol 2005; 174: 864–70
   PubMed Web of Science ®Google Scholar
• Burger J. A., Zvaifler N. J., Tsukada N., Firestein G. S., Kipps T. J. Fibroblast‐like synoviocytes support B‐cell pseudoemperipolesis via a stromal cell‐derived factor‐1‐ and CD106 (VCAM‐1)‐dependent mechanism. J Clin Invest 2001; 107: 305–15
   PubMed Web of Science ®Google Scholar
• Shi K., Hayashida K., Kaneko M., Hashimoto J., Tomita T., Lipsky P. E., et al. Lymphoid chemokine B cell‐attracting chemokine‐1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients. J Immunol 2001; 166: 650–5
   PubMed Web of Science ®Google Scholar
• Takemura S., Braun A., Crowson C., Kurtin P. J., Cofield R. H., O'Fallon W. M., et al. Lymphoid neogenesis in rheumatoid synovitis. J Immunol 2001; 167: 1072–80
   PubMed Web of Science ®Google Scholar
• Morales‐Ducret J., Wayner E., Elices M. J., Alvaro‐Gracia J. M., Zvaifler N. J., Firestein G. S. Alpha 4/beta 1 integrin (VLA‐4) ligands in arthritis. Vascular cell adhesion molecule‐1 expression in synovium and on fibroblast‐like synoviocytes. J Immunol 1992; 149: 1424–31
   PubMed Web of Science ®Google Scholar
• Cho M. L., Yoon C. H., Hwang S. Y., Park M. K., Min S. Y., Lee S. H., et al. Effector function of type II collagen‐stimulated T cells from rheumatoid arthritis patients: cross‐talk between T cells and synovial fibroblasts. Arthritis Rheum 2004; 50: 776–84
   PubMed Web of Science ®Google Scholar
• Hallbeck A. L., Walz T. M., Briheim K., Wasteson A. TGF‐alpha and ErbB2 production in synovial joint tissue: increased expression in arthritic joints. Scand J Rheumatol 2005; 34: 204–11
   PubMed Web of Science ®Google Scholar
• Popko J., Marciniak J., Zalewska A., Maldyk P., Rogalski M., Zwierz K. The activity of exoglycosidases in the synovial membrane and knee fluid of patients with rheumatoid arthritis and juvenile idiopathic arthritis. Scand J Rheumatol 2006; 35: 189–92
   PubMed Web of Science ®Google Scholar
• Tsubaki T., Takegawa S., Hanamoto H., Arita N., Kamogawa J., Yamamoto H., et al. Accumulation of plasma cells expressing CXCR3 in the synovial sublining regions of early rheumatoid arthritis in association with production of Mig/CXCL9 by synovial fibroblasts. Clin Exp Immunol 2005; 141: 363–71
   PubMed Web of Science ®Google Scholar
• Nishio M., Endo T., Tsukada N., Ohata J., Kitada S., Reed J. C., et al. Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF‐1{alpha}. Blood 2005; 106: 1012–20
   PubMed Web of Science ®Google Scholar